1. Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
    Yiyang Qin et al, 2017, Cancer Cell International CrossRef
  2. Fabrication and investigation potential effect of lentinan and docetaxel nanofibers for synergistic treatment of breast cancer in vitro
    Hanieh Ataollahi et al, 2022, Polymers for Advanced Technologies CrossRef
  3. Investigation of HER-3 gene expression under the influence of carbohydrate biopolymers extract of shiitake and reishi in MCF-7 cell line
    Mohaddeseh Larypoor, 2022, Molecular Biology Reports CrossRef
  4. Design, Synthesis and Antitumor Activity of Quinazoline Derivatives Bearing 2,3-Dihydro-indole or 1,2,3,4-Tetrahydroquinoline
    Yiqiang OuYang et al, 2019, Letters in Drug Design & Discovery CrossRef
  5. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors
    Yiqiang OuYang et al, 2018, European Journal of Medicinal Chemistry CrossRef
  6. SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells
    Ping Tian et al, 2024, PLOS ONE CrossRef
  7. HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma
    Laura Hüser et al, 2020, Cancers CrossRef
  8. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min et al, 2021, Archives of Pharmacal Research CrossRef
  9. C‐Dimethylated Flavones as Possible Potential Anti‐Tubercular and Anticancer Agents.
    Hari Babu Bollikolla et al, 2023, Chemistry & Biodiversity CrossRef
  10. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer
    Ping Tian et al, 2024, Cell Biochemistry and Biophysics CrossRef
  11. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing oxazole or imidazole as potential EGFR inhibitors
    Yiqiang OuYang et al, 2018, New Journal of Chemistry CrossRef
  12. Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents
    Shuang Hao et al, 2024, Bioorganic Chemistry CrossRef